Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
44
BIO Quote, Financials, Valuation and Earnings
Last price:
$327.54
Seasonality move
:
8.52%
Day range:
$325.72 - $334.10
52-week range:
$262.12 - $387.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.61x
P/B ratio:
1.22x
Volume:
660.4K
Avg. volume:
204.3K
1-year change:
6.21%
Market cap:
$9.2B
Revenue:
$2.7B
EPS (TTM):
-$27.33
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.3B | $2.5B | $2.9B | $2.8B | $2.7B | |
| Revenue Growth (YoY) | 0.97% | 10.12% | 14.81% | -4.12% | -4.67% | |
| Cost of Revenues | $1.1B | $1.1B | $1.3B | $1.2B | $1.2B | |
| Gross Profit | $1.3B | $1.4B | $1.6B | $1.6B | $1.4B | |
| Gross Profit Margin | 54.38% | 56.49% | 56.05% | 55.93% | 53.42% | |
| R&D Expenses | $202.7M | $217.8M | $260.6M | $256.9M | $247.4M | |
| Selling, General & Admin | $824.6M | $798.8M | $877.1M | $827.8M | $841.7M | |
| Other Inc / (Exp) | $2B | $4.5B | $4.9B | -$5.2B | -$1.2B | |
| Operating Expenses | $1B | $1B | $1.1B | $1.1B | $1.1B | |
| Operating Income | $229.7M | $421.3M | $500.3M | $475.1M | $337.8M | |
| Net Interest Expenses | -- | $3.7M | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.3B | $4.9B | $5.4B | -$4.7B | -$850.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $502.4M | $1.1B | $1.2B | -$1.1B | -$212.8M | |
| Net Income to Company | $1.8B | $3.8B | $4.3B | -$3.6B | -$637.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.8B | $3.8B | $4.3B | -$3.6B | -$637.3M | |
| Basic EPS (Cont. Ops) | $58.93 | $128.13 | $142.61 | -$121.79 | -$21.82 | |
| Diluted EPS (Cont. Ops) | $58.27 | $126.47 | $140.83 | -$121.79 | -$21.82 | |
| Weighted Average Basic Share | $29.8M | $29.8M | $29.8M | $29.8M | $29.2M | |
| Weighted Average Diluted Share | $30.2M | $30.2M | $30.2M | $29.8M | $29.2M | |
| EBITDA | $2.4B | $5.1B | $5.6B | -$4.5B | -$654.8M | |
| EBIT | $2.3B | $4.9B | $5.5B | -$4.7B | -$800.7M | |
| Revenue (Reported) | $2.3B | $2.5B | $2.9B | $2.8B | $2.7B | |
| Operating Income (Reported) | $229.7M | $421.3M | $500.3M | $475.1M | $337.8M | |
| Operating Income (Adjusted) | $2.3B | $4.9B | $5.5B | -$4.7B | -$800.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $647.3M | $747M | $680.8M | $632.1M | $649.7M | |
| Revenue Growth (YoY) | 15.45% | 15.42% | -8.87% | -7.15% | 2.79% | |
| Cost of Revenues | $280M | $309.6M | $308.2M | $296.4M | $293.8M | |
| Gross Profit | $367.3M | $437.4M | $372.6M | $335.7M | $355.9M | |
| Gross Profit Margin | 56.75% | 58.56% | 54.73% | 53.1% | 54.78% | |
| R&D Expenses | $59.5M | $64.5M | $66.8M | $43.5M | $91M | |
| Selling, General & Admin | $198.2M | $216.2M | $211.1M | $201.2M | $200.4M | |
| Other Inc / (Exp) | $1.6B | $4.9B | -$298.3M | $41.2M | $793.8M | |
| Operating Expenses | $257.7M | $280.6M | $277.9M | $244.7M | $291.4M | |
| Operating Income | $109.6M | $156.8M | $94.6M | $90.9M | $64.5M | |
| Net Interest Expenses | $3.9M | $726K | $3.7M | -- | -- | |
| EBT. Incl. Unusual Items | $1.7B | $5B | -$207.3M | $137.1M | $861.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $369.6M | $1.1B | -$44.5M | $30.8M | $208.4M | |
| Net Income to Company | $1.3B | $3.9B | -$162.8M | $106.3M | $653.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.3B | $3.9B | -$162.8M | $106.3M | $653.2M | |
| Basic EPS (Cont. Ops) | $44.24 | $131.75 | -$5.48 | $3.65 | $23.37 | |
| Diluted EPS (Cont. Ops) | $43.64 | $129.96 | -$5.48 | $3.64 | $23.34 | |
| Weighted Average Basic Share | $29.7M | $29.8M | $29.7M | $29.1M | $27.9M | |
| Weighted Average Diluted Share | $30.1M | $30.2M | $29.7M | $29.2M | $28M | |
| EBITDA | $1.7B | $5.1B | -$161.4M | $186.8M | $912.7M | |
| EBIT | $1.7B | $5B | -$195.7M | $149.5M | $873.8M | |
| Revenue (Reported) | $647.3M | $747M | $680.8M | $632.1M | $649.7M | |
| Operating Income (Reported) | $109.6M | $156.8M | $94.6M | $90.9M | $64.5M | |
| Operating Income (Adjusted) | $1.7B | $5B | -$195.7M | $149.5M | $873.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $3B | $2.8B | $2.7B | $2.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.1B | $1.3B | $1.2B | $1.3B | $1.2B | |
| Gross Profit | $1.3B | $1.7B | $1.6B | $1.5B | $1.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $217.9M | $258.7M | $249.5M | $249.7M | $280.2M | |
| Selling, General & Admin | $795.3M | $873.1M | $837.3M | $846.8M | $817.2M | |
| Other Inc / (Exp) | $4.2B | $8B | -$8.3B | -$588.5M | -$1.3B | |
| Operating Expenses | $1B | $1.1B | $1.1B | $1.1B | $1.1B | |
| Operating Income | $294.9M | $568.1M | $481.8M | $353.6M | $306M | |
| Net Interest Expenses | -- | $1.9M | -- | -- | -- | |
| EBT. Incl. Unusual Items | $4.5B | $8.6B | -$7.8B | -$187.2M | -$1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1B | $1.9B | -$1.8B | -$27.9M | -$226.5M | |
| Net Income to Company | $3.5B | $6.7B | -$6B | -$159.2M | -$778.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3.5B | $6.7B | -$6B | -$159.3M | -$778.7M | |
| Basic EPS (Cont. Ops) | $118.30 | $223.36 | -$201.62 | -$5.72 | -$27.28 | |
| Diluted EPS (Cont. Ops) | $116.82 | $220.47 | -$201.62 | -$5.85 | -$27.33 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $4.7B | $8.7B | -$7.7B | $5.7M | -$806.5M | |
| EBIT | $4.6B | $8.6B | -$7.8B | -$138.5M | -$956.1M | |
| Revenue (Reported) | $2.4B | $3B | $2.8B | $2.7B | $2.6B | |
| Operating Income (Reported) | $294.9M | $568.1M | $481.8M | $353.6M | $306M | |
| Operating Income (Adjusted) | $4.6B | $8.6B | -$7.8B | -$138.5M | -$956.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $2.2B | $2.1B | $2B | $1.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $778.1M | $950.1M | $901.7M | $929.5M | $862M | |
| Gross Profit | $977.7M | $1.2B | $1.2B | $1.1B | $1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $160.8M | $201.8M | $190.7M | $183.5M | $216.3M | |
| Selling, General & Admin | $581.1M | $655.4M | $615.6M | $634.6M | $610M | |
| Other Inc / (Exp) | $3.6B | $7.1B | -$6.2B | -$1.6B | -$1.7B | |
| Operating Expenses | $742M | $857.2M | $806.3M | $818.1M | $826.3M | |
| Operating Income | $235.7M | $382.4M | $363.9M | $242.5M | $210.7M | |
| Net Interest Expenses | $9.6M | $1.1M | $8.9M | -- | -- | |
| EBT. Incl. Unusual Items | $3.8B | $7.5B | -$5.8B | -$1.3B | -$1.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $861.9M | $1.7B | -$1.3B | -$291.5M | -$305.2M | |
| Net Income to Company | $3B | $5.8B | -$4.5B | -$987M | -$1.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3B | $5.8B | -$4.5B | -$987M | -$1.1B | |
| Basic EPS (Cont. Ops) | $99.80 | $195.23 | -$149.03 | -$33.61 | -$39.43 | |
| Diluted EPS (Cont. Ops) | $98.51 | $192.66 | -$149.03 | -$33.63 | -$39.47 | |
| Weighted Average Basic Share | $89.2M | $89.4M | $89.5M | $88.1M | $84.9M | |
| Weighted Average Diluted Share | $90.4M | $90.6M | $89.5M | $88.3M | $84.9M | |
| EBITDA | $3.9B | $7.6B | -$5.7B | -$1.1B | -$1.3B | |
| EBIT | $3.8B | $7.5B | -$5.8B | -$1.2B | -$1.4B | |
| Revenue (Reported) | $1.8B | $2.2B | $2.1B | $2B | $1.9B | |
| Operating Income (Reported) | $235.7M | $382.4M | $363.9M | $242.5M | $210.7M | |
| Operating Income (Adjusted) | $3.8B | $7.5B | -$5.8B | -$1.2B | -$1.4B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $660.7M | $662.2M | $470.8M | $434.2M | $403.8M | |
| Short Term Investments | $454M | $328.9M | $399.1M | $1.4B | $1.2B | |
| Accounts Receivable, Net | $392.7M | $419.4M | $423.5M | $494.6M | $489M | |
| Inventory | $554M | $622.3M | $572.2M | $719.3M | $780.5M | |
| Prepaid Expenses | $102.3M | $90.6M | $109.1M | $124.2M | $140M | |
| Other Current Assets | $10.9M | $10.9M | $10.1M | $23.6M | $26.1M | |
| Total Current Assets | $2.2B | $2.1B | $2B | $3.2B | $3B | |
| Property Plant And Equipment | $701.2M | $693.5M | $716.4M | $679.6M | $723.7M | |
| Long-Term Investments | $4.6B | $9.6B | $14.4B | $8.8B | $7.7B | |
| Goodwill | $264.1M | $291.9M | $347.3M | $406.5M | $413.6M | |
| Other Intangibles | $145.5M | $199.5M | $253.9M | $332.1M | $320.5M | |
| Other Long-Term Assets | $79.6M | $86.7M | $104.2M | $94.6M | $94.9M | |
| Total Assets | $8B | $13B | $17.8B | $13.5B | $12.3B | |
| Accounts Payable | $107M | $139.5M | $141.9M | $135M | $144.6M | |
| Accrued Expenses | $180.1M | $222.9M | $277M | $194.8M | $139.9M | |
| Current Portion Of Long-Term Debt | $425.7M | $1.3M | $489K | $465K | $486K | |
| Current Portion Of Capital Lease Obligations | $35.9M | $37M | $36.4M | $36.3M | $40.4M | |
| Other Current Liabilities | $86.8M | $131.1M | $127.9M | $169.6M | $161.6M | |
| Total Current Liabilities | $905.5M | $631.5M | $680.9M | $568.7M | $522.8M | |
| Long-Term Debt | $2.4M | $1.3M | $10.5M | $1.2B | $1.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.3B | $3.1B | $4.1B | $3.9B | $3.6B | |
| Common Stock | $3K | $3K | $3K | $3K | $3K | |
| Other Common Equity Adj | -$87.3M | $282.5M | -$175.6M | -$466.8M | -$336M | |
| Common Equity | $5.8B | $9.9B | $13.7B | $9.6B | $8.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5.8B | $9.9B | $13.7B | $9.6B | $8.7B | |
| Total Liabilities and Equity | $8B | $13B | $17.8B | $13.5B | $12.3B | |
| Cash and Short Terms | $1.1B | $991.1M | $869.9M | $1.8B | $1.6B | |
| Total Debt | $428.1M | $2.6M | $11M | $1.2B | $1.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $840.3M | $859.9M | $517.9M | $457.9M | $410.4M | |
| Short Term Investments | $314.1M | $477.2M | $1.3B | $1.3B | $1.2B | |
| Accounts Receivable, Net | $402.2M | $417.7M | $432.3M | $457.4M | $461.9M | |
| Inventory | $640.2M | $588.9M | $685.9M | $775.8M | $804.3M | |
| Prepaid Expenses | $111.3M | $104.6M | $147.2M | $123.9M | $133.2M | |
| Other Current Assets | $10.1M | $12.4M | $19.1M | $25.1M | $28.2M | |
| Total Current Assets | $2.3B | $2.5B | $3.1B | $3.1B | $3.1B | |
| Property Plant And Equipment | $677.6M | $680.8M | $632.7M | $711.4M | $719.2M | |
| Long-Term Investments | $8.4B | $16.2B | $7.5B | $7.2B | $6B | |
| Goodwill | $291.9M | $291.9M | $399.6M | $407M | $415.1M | |
| Other Intangibles | $205.3M | $177.1M | $325.1M | $314.2M | $307.3M | |
| Other Long-Term Assets | $82.4M | $106.6M | $101.8M | $98.5M | $103.6M | |
| Total Assets | $12B | $20B | $12.1B | $11.9B | $10.6B | |
| Accounts Payable | $133M | $136.4M | $142.7M | $111.9M | $122.2M | |
| Accrued Expenses | $190.1M | $243.9M | $192.5M | $154.9M | $146M | |
| Current Portion Of Long-Term Debt | $426.1M | $1.2M | -- | -- | $1.3M | |
| Current Portion Of Capital Lease Obligations | $34.9M | $36.6M | $34.4M | $39.6M | $42.8M | |
| Other Current Liabilities | $160.9M | $177.8M | $171.8M | $147.8M | $142M | |
| Total Current Liabilities | $986.7M | $649.9M | $570.7M | $558.2M | $497.9M | |
| Long-Term Debt | $1.1M | -- | $1.2B | $1.2B | $1.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.2B | $4.6B | $3.6B | $3.5B | $3.1B | |
| Common Stock | $3K | $3K | $3K | $3K | $3K | |
| Other Common Equity Adj | $84M | -$63M | -$845.2M | -$497.6M | -$315.3M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $8.8B | $15.3B | $8.5B | $8.4B | $7.5B | |
| Total Liabilities and Equity | $12B | $20B | $12.1B | $11.9B | $10.6B | |
| Cash and Short Terms | $1.2B | $1.3B | $1.9B | $1.8B | $1.6B | |
| Total Debt | $427.2M | $1.2M | $1.2B | $1.2B | $1.2B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.8B | $3.8B | $4.3B | -$3.6B | -$637.3M | |
| Depreciation & Amoritzation | $134.2M | $138.6M | $137.6M | $137.3M | $145.9M | |
| Stock-Based Compensation | $35.6M | $41.6M | $51.2M | $60.9M | $61.3M | |
| Change in Accounts Receivable | $1.6M | -$15M | -$20.4M | -$87.4M | $11.4M | |
| Change in Inventories | $24.2M | -$52.1M | $46.1M | -$158.8M | -$46.3M | |
| Cash From Operations | $457.9M | $585M | $669.5M | $194.4M | $374.9M | |
| Capital Expenditures | $98.5M | $108.6M | $133.7M | $114.2M | $156.7M | |
| Cash Acquisitions | -$79.4M | -$84.4M | -$125.5M | -$99.4M | $2.5M | |
| Cash From Investing | -$208.9M | -$69.9M | -$797.4M | -$1.2B | $20.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $1.2B | -- | |
| Long-Term Debt Repaid | -$643K | -$426.9M | -$3M | -$510K | -$467K | |
| Repurchase of Common Stock | -$28M | -$100M | -$50M | -$215.7M | -$428.7M | |
| Other Financing Activities | -$11.1M | -$16.3M | -$23M | -$14M | -$14.9M | |
| Cash From Financing | -$22.8M | -$523M | -$55.4M | $973.6M | -$425.6M | |
| Beginning Cash (CF) | $434.2M | $662.7M | $667.1M | $471.1M | $434.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $226.3M | -$8M | -$183.3M | -$39.6M | -$30.5M | |
| Ending Cash (CF) | $662.7M | $667.1M | $471.1M | $434.5M | $404.4M | |
| Levered Free Cash Flow | $359.4M | $476.4M | $535.7M | $80.3M | $218.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.3B | $3.9B | -$162.8M | $106.3M | $653.2M | |
| Depreciation & Amoritzation | $33.6M | $33.7M | $34.3M | $37.3M | $38.9M | |
| Stock-Based Compensation | $10.8M | $13.1M | $15.7M | $15.9M | $15.6M | |
| Change in Accounts Receivable | -$34.3M | -$23.4M | $1.3M | $26.4M | -$7.4M | |
| Change in Inventories | -$3.7M | $13.9M | -$48.3M | -$6.4M | $15.2M | |
| Cash From Operations | $135.7M | $230.4M | $11M | $97.7M | $163.6M | |
| Capital Expenditures | $20M | $34.6M | $27.6M | $44.1M | $63.6M | |
| Cash Acquisitions | $234K | -- | -$100.7M | -- | -- | |
| Cash From Investing | $90.9M | -$81.4M | -$88.4M | -$9.5M | -$55.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$183K | -$122K | -$113K | -$118K | -$123K | |
| Repurchase of Common Stock | $1K | -- | -- | -$21.3M | -$97.8M | |
| Other Financing Activities | -$6.4M | -$21.8M | -$13.4M | -$9.8M | -$3.1M | |
| Cash From Financing | $439K | -$15.6M | -$8.8M | -$26.6M | -$96M | |
| Beginning Cash (CF) | $612.1M | $737.2M | $596.9M | $390.5M | $407.7M | |
| Foreign Exchange Rate Adjustment | $6M | -$6.1M | $7.5M | $6.2M | -$7.5M | |
| Additions / Reductions | $227M | $133.4M | -$86.2M | $61.6M | $12M | |
| Ending Cash (CF) | $845.1M | $864.5M | $518.2M | $458.3M | $412.2M | |
| Levered Free Cash Flow | $115.7M | $195.7M | -$16.5M | $53.6M | $100M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.5B | $6.7B | -$6B | -$159.2M | -$778.7M | |
| Depreciation & Amoritzation | $136.3M | $136.8M | $139.3M | $144.2M | $149.6M | |
| Stock-Based Compensation | $39.5M | $48.5M | $57.8M | $63.2M | $62.1M | |
| Change in Accounts Receivable | -$38.4M | -$15.9M | -$54.4M | -$11.3M | $5.4M | |
| Change in Inventories | -$44.8M | $59.6M | -$132.7M | -$69.9M | -$600K | |
| Cash From Operations | $450.4M | $793M | $285.7M | $373.6M | $412.1M | |
| Capital Expenditures | $81.4M | $126.3M | $134.2M | $150.6M | $188.3M | |
| Cash Acquisitions | -$88M | -- | -$224.9M | -- | -- | |
| Cash From Investing | -$71.3M | -$289.7M | -$1.7B | -$110.5M | -$57.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $1.2B | -- | -- | |
| Long-Term Debt Repaid | -$1.9M | -$426.8M | -$1.7M | -$492K | -$477K | |
| Repurchase of Common Stock | -$108M | -$50M | -- | -$319.4M | -$403.6M | |
| Other Financing Activities | -$14.6M | -- | -- | -- | -$8.7M | |
| Cash From Financing | -$105.9M | -$481.9M | $1.1B | -$311.6M | -$393.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $273.1M | $21.3M | -$366M | -$48.6M | -$38.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $369M | $666.6M | $151.5M | $222.9M | $223.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3B | $5.8B | -$4.5B | -$987M | -$1.1B | |
| Depreciation & Amoritzation | $101.9M | $100.1M | $101.8M | $108.7M | $112.4M | |
| Stock-Based Compensation | $29.3M | $36.2M | $42.8M | $45.1M | $45.9M | |
| Change in Accounts Receivable | -$9.6M | -$10.5M | -$44.5M | $31.6M | $25.6M | |
| Change in Inventories | -$83.5M | $28.2M | -$150.6M | -$61.7M | -$16M | |
| Cash From Operations | $290.6M | $498.6M | $114.8M | $293.9M | $331M | |
| Capital Expenditures | $59.8M | $77.6M | $78M | $114.4M | $146.1M | |
| Cash Acquisitions | -$84.4M | -- | -$99.4M | -- | -- | |
| Cash From Investing | -$10.1M | -$230M | -$1.1B | -$52M | -$129.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $1.2B | -- | -- | |
| Long-Term Debt Repaid | -$1.8M | -$1.6M | -$367K | -$349K | -$359K | |
| Repurchase of Common Stock | -$100M | -$50M | -$125M | -$228.7M | -$203.6M | |
| Other Financing Activities | -$14.6M | -$22.9M | -$13.9M | -$10.1M | -$3.9M | |
| Cash From Financing | -$101.2M | -$60.1M | $1.1B | -$225M | -$192.6M | |
| Beginning Cash (CF) | $1.9B | $2.1B | $1.9B | $1.3B | $1.2B | |
| Foreign Exchange Rate Adjustment | $3.2M | -$11.2M | $21.2M | $6.9M | -$1M | |
| Additions / Reductions | $179.3M | $208.6M | $25.9M | $16.9M | $8.8M | |
| Ending Cash (CF) | $2.1B | $2.3B | $1.9B | $1.3B | $1.3B | |
| Levered Free Cash Flow | $230.8M | $421M | $36.8M | $179.5M | $185M | |
Get BIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BIO
Sector
P/E ratio
--
25.86x
PEG ratio
-0.03x
0.00x
P/B ratio
1.22x
1.84x
Price / LTM sales
3.61x
1.86x
Growth Metrics
BIO
Sector
Revenue growth
2.79%
7.1%
Earnings growth
541.21%
1.82%
Revenue (5-year growth)
3.13%
8.72%
Earnings forecast
$1.18
-$0.20
Profitability
BIO
Sector
Profitability FY 2023
$1.4B
$57.1M
Return on invested capital
-8.38%
-14.09%
Return on assets
-6.82%
-11.79%
Return on equity
-9.62%
-14.85%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
14
Estimated Next Earnings Date
Jan
29
Balance Sheet
BIO
Sector
Total cash
$1.6B
$46.9M
Short term investments
$1.2B
$44M
Total assets
$12.3B
$142M
Long term debt
$1.2B
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 1.47% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 10% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 1.24% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
